Saturday, July 05, 2025

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Clinical Trials Now Required for Annual COVID Shots Given to Healthy Adults

by Amber Baker
doctor and patient
On May 20, 2025, the U.S. Food and Drug Administration (FDA) announced that new clinical trials will be required to approve annual ...

CDC Vaccine Advisory Panel Purged

by Marco Cáceres
woman carrying box
On June 9, 2025, U.S. Secretary of Health and Human Services Robert F. Kennedy, Jr. fired all 17 members of the U.S ...

FDA Approves MenQuadfi Meningococcal Vaccine for Six-Week-Old Infants

by Amber Baker and Barbara Loe Fisher
vaccinating an infant
The U.S. Food and Drug Administration (FDA) has licensed Sanofi’ SA’s four-valent MenQuadfi meningococcal vaccine for use in infants aged six weeks ...

Government Cancels $700 Million in Funding for Moderna’s Bird Flu Biologic

by Natasha Hobley
bird flu vaccine
The U.S. government has cancelled a contract worth over $700 million awarded to Moderna, Inc. for late-stage development of an mRNA bird ...

FDA Licenses Moderna’s mNEXSPIKE COVID Shot for Individuals at High Risk for Severe COVID Disease

by Rishma Parpia
mNEXSPIKE biologic
On May 30, 2025, the U.S. Food and Drug Administration (FDA) licensed mNEXSPIKE (mRNA-1283), a newly developed mRNA COVID-19 biologic for individuals ...

Moderna Withdraws Application for Combination COVID and Flu Vaccine

by Natasha Hobley
covid and flu
Moderna, Inc. withdrew its application for United States licensure for its combination COVID-19/Influenza vaccine known as mRNA-1083. The company stated the decision ...

Meningitis B Vaccine to Be Used for Gonorrhea in England

by Amber Baker
sexually transmitted disease
In August 2025, England will become the first country to offer a vaccine for gonorrhea after cases exceed 85,000 in 2023—the highest ...

FDA Approves Novavax’s COVID-19 Vaccine With Restrictions

by Rishma Parpia
Novavax COVID vaccine
On May 16, 2025, the U.S. Food and Drug Administration (FDA) approved licensure of Novavax, Inc.’s Nuvaxovid protein-based COVID-19 vaccine, which has ...

In this section

Search in Archive

Search in Site

To search in site, type your keyword and hit enter

Search
The Vaccine Reaction
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.